RecruitingNCT04394052

Novel Imaging Techniques for the Characterization of Musculoskeletal Tumors II

Novel Imaging Techniques for the Characterization of Musculoskeletal Tumors II: Texture Analysis and Artificial Intelligence


Sponsor

Central Hospital, Nancy, France

Enrollment

740 participants

Start Date

Jun 1, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

This study aims at evaluating the value of various artificial intelligence based techniques to improve the characterization and image post-processing for patients with musculoskeletal tumors.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying MR imaging for people with bone neoplasm and soft tissue neoplasm. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTMR imaging

Medical imaging


Locations(1)

CHU-Nancy

Nancy, Lorraine, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04394052


Related Trials